Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™ for the treatment of refractory angina and the Tiara™ technology in development for the transcatheter treatment of mitral valve disease. To receive Neovasc updates via email, please register at: http://www.neovasc.com/register.